Physician

Nicholas Darrow Marchase, M.D.

According to 2025 Medicare claims, Nicholas Marchase, M.D. (NPI: 1518226372) practices ophthalmology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is SOUTH CAROLINA RETINA INSTITUTE LLC (NPI: 1417581638; TIN: 843234305) and primary practice location at 29526-3567.

Marchase's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 829 traditional Medicare patients, billed 171,689 HCPCS/CPT codes, and received $5,308,040 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 806 prescription claims across 261 beneficiaries totaling $47,536 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 28 records totaling $620. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,180,657 to $5,308,040. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $12,173 to $47,536. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	552	2,785	$1,180,657
2017	913	5,162	$1,914,059
2018	435	1,698	$450,985
2019	396	4,395	$768,443
2020	436	4,235	$666,454
2021	721	10,867	$1,787,229
2022	843	16,671	$2,822,269
2023	770	82,410	$4,106,564
2024	829	171,689	$5,308,040

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	165	$12,173
2016	33	117	$7,149
2017	51	80	$5,710
2018	40	89	$9,484
2019	171	555	$29,406
2020	121	391	$26,693
2021	186	733	$34,306
2022	253	1,058	$54,168
2023	303	1,087	$70,057
2024	261	806	$47,536

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	405	2,302	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	637	1,027	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	318	523	$70
92134	Imaging of retina	780	2,632	$31
J2777	Injection, faricimab-svoa, 0.1 mg	363	152,344	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	21	1,095	$22,563
Prednisolone Acetate	Prednisolone Acetate	179	6,166	$8,330
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	173	11,682	$2,568
Brimonidine Tartrate	Brimonidine Tartrate	66	3,508	$1,377
Ofloxacin	Ofloxacin	81	1,777	$1,108

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$620	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas Darrow Marchase, M.D.?

Tedicare shows public-source Medicare data for Nicholas Darrow Marchase, M.D. (NPI 1518226372), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas Darrow Marchase, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nicholas Darrow Marchase, M.D.?

Nicholas Darrow Marchase, M.D. is linked to SOUTH CAROLINA RETINA INSTITUTE LLC (billing NPI 1417581638) in the available physician profile data.

Does Nicholas Darrow Marchase, M.D. have Open Payments data?

Nicholas Darrow Marchase, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.